Anthony N. Amato - 11 Sep 2024 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director
Signature
/s/ Anthony Amato
Issuer symbol
BSGM
Transactions as of
11 Sep 2024
Net transactions value
$0
Form type
4
Filing time
13 Sep 2024, 16:05:21 UTC
Previous filing
05 Jul 2024
Next filing
29 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Award $0 +275,000 +49% $0.000000 833,202 11 Sep 2024 Direct F1
transaction BSGM Common Stock Award $0 +1,275,000 +153% $0.000000 2,108,202 11 Sep 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Option (right to buy) Award +2,400,000 2,400,000 11 Sep 2024 Common Stock 2,400,000 $0.4479 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of restricted stock were granted and fully vested as of September 11, 2024 (the "Date of Grant"), based on a closing price of $0.4479 per share on such date.
F2 The shares of restricted stock vest biannually over three years in equal installments with vesting commencing on the Date of Grant, based on the closing price of $.04479 per share on such date.
F3 The option to purchase shares of the Issuers common stock (the "Option") has an exercise price of $0.4479 per share. 1,200,000 of the Option vested and became exercisable on the Date of Grant and the remaining 1,200,000 unvested Option will vest bi-annually over the term of 3 years commencing on the Date of Grant, subject to continued service with the Company through each relevant vesting date.